XML 61 R47.htm IDEA: XBRL DOCUMENT v3.25.1
Discontinued Operations - Schedule of Book Value of Assets and Liabilities (Details) - Discontinued Operations, Disposed of by Sale - Elusys Therapeutics
Dec. 27, 2023
USD ($)
Discontinued Operations  
Cash and cash equivalents $ 252,423
Prepaid expenses and deposits 30,228
Intangibles and other long-term assets 6,728,109
Accounts payable (197,082)
Accrued expenses and other liabilities (1,183,129)
Contingent royalty earnout liability (4,610,000)
Net book value of assets and liabilities sold $ 1,020,549